McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, 1400 University Ave, Madison, WI 53706, USA1
Author for correspondence: Bill Sugden. Fax +1 608 262 2824. e-mail sugden{at}oncology.wisc.edu
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() |
---|
![]() |
Main text |
---|
![]() ![]() ![]() ![]() |
---|
|
Mutations in LMP-1 were generated that disrupt the amino terminus and transmembrane regions of the protein (Fig. 1). N
43 removes the first 43 aa of LMP-1, including the first transmembrane region. N
1220 removes aa 1220 of LMP-1, deleting a large portion of the putative SH3-binding region PPGPRRPPRGPP. SH3-binding regions bind to proteins that contain SH3 domains, often through PXXP motifs found within the region (Feng et al., 1994
). Proteins that contain SH3 domains are typically found to be involved in cell signalling pathways (e.g. c-Src, c-Abl) (Koch et al., 1991
; Mayer & Baltimore, 1993
). 12,15,16,19,20 P
A disrupts PXXP motifs within this region by replacing prolines with alanines at aa 12, 15, 16, 19 and 20. A subset of mutants used in these studies was constructed, members of which possessed an epitope tag within the amino termini of the resulting proteins, such that the topologies of these proteins within the plasma membrane could be determined via immunofluorescent cell analysis (see below). 6M EE contains the six transmembrane regions of LMP-1 and an epitope from polyomavirus middle T antigen (EE) (Grussenmeyer et al., 1985
; Wilson & Bourne, 1995
) in place of aa 1220. 6M HA contains the six transmembrane regions of LMP-1 and the influenza virus haemagglutinin epitope (HA) (Wilson et al., 1984
; Arden et al., 1995
) in place of aa 35. 4M HA has transmembrane regions 1 and 2 of LMP-1 deleted, but retains the HA tag in the same context as in 6M HA. These mutants all contain the wild-type carboxy terminus of LMP-1 (aa 200386), which in turn contains the epitopes of LMP-1 recognized by our rabbit antiserum.
The topologies of the 6M EE, 6M HA and 4M HA mutants within the membrane were established by determining the positions of the epitope tags found on the amino and carboxy termini of these proteins as being inside or outside the cells. 293 cells were transfected with mutant DNA constructs via calcium phosphate precipitation (Sambrook et al., 1989 ). Various times after transfection, the cells were harvested and resuspended in impermeable cell wash [1x PBS, 10% bovine calf serum (BCS), 0·05% sodium azide (NaAz)], and distributed into two sets of tubes. Cells in one set of tubes remained resuspended in impermeable cell wash and were defined as the impermeable set. Cells in the second set of tubes were pelleted and resuspended in permeable cell wash (1x PBS, 10% BCS, 0·05% NaAz, 0·01% saponin), and defined as the permeable set. Primary antibody was added to both sets. The EE epitope was detected with mouse monoclonal anti-EE antibody (Grussenmeyer et al., 1985
); the HA epitope was detected by mouse monoclonal anti-HA antibody (HA-11, BAbCO); the LMP-1 epitopes were detected by affinity-purified polyclonal rabbit anti-LMP-1 antibody (Baichwal & Sugden, 1987
). Both sets of cells were washed and the appropriate fluorescein-conjugated secondary antibody was added, goat anti-rabbit IgG (Jackson) or goat anti-mouse IgG (Boehringer Mannheim Biochemical). Both sets of cells were washed and resuspended in 1x PBS. The cells were fixed with 2% paraformaldehyde, washed in 1x PBS, resuspended in PBS and analysed for fluorescence using an EPICS Profile Analyser.
The results of the immunofluorescent cell analyses indicate that the insertion of either the EE or HA epitope into the amino terminus does not alter the wild-type topology of the resulting protein. Table 1(a) shows the percentage of cells scored as specifically stained by antibody for either permeable or impermeable cells. For both 6M EE and 6M HA, the detection of amino- or carboxy-terminal epitopes is more efficient in cells that are permeable than cells that are impermeable, consistent with these regions of the proteins being found on the inside of the cells. Similar results using 4M HA in these assays indicate that the removal of transmembrane regions 1 and 2 does not disrupt the wild-type topology of the resulting protein (Table 1a)
. The topologies of these proteins were interpreted based on the positions of both the amino and carboxy termini, and these topologies are indicated in Fig. 1
. As a control, 1M HA (Fig. 1
) was used to determine our ability to detect epitopes found on the outside of the cell. 1M HA is predicted to place both an HA epitope and LMP-1 epitopes on the outside of the cell. The results using 1M HA show that the HA epitope can be detected on impermeable cells and the LMP-1 epitopes can be detected on both permeable and impermeable cells, consistent with the epitopes being placed on the outside of the cell.
|
|
|
One possible explanation for the role of aa 1220 in patching results from the fact that it contains a putative SH3-binding region located between aa 9 and 20. This putative SH3-binding region has three PXXP motifs (PPGP, PRRP, PRGP), which might facilitate patching of LMP-1 through associations with cytoskeletal or adaptor proteins (some of which are known to contain SH3 domains) (Mayer & Baltimore, 1993 ). We performed filter-binding assays according to Cicchetti et al. (1992)
and demonstrated that the amino terminus of LMP-1 bound to the SH3 domain of c-Abl fused to glutathione S-transferase (GST) 4·5-fold more than GST alone, while a positive control, 3BP1-10 fused to GST (Ren et al., 1993
), bound the SH3 domain of c-Abl 3·5-fold more than GST alone in these assays. Disruption of the SH3-binding region of LMP-1 in these assays decreased binding to background levels.
To test the importance of the putative SH3-binding region of LMP-1 for patching activity, mutants N1220 and 12,15,16,19,20 P
A were tested in patching assays. Removal of aa 1220 resulted in a protein that could not patch, while disruption of putative SH3-binding in this region did not affect patching (Table 1b)
. Thus, while the region between residues 12 and 20 of LMP-1 contributes to patching, the SH3-binding activity within this region is not required for patching.
Results of assays that measured the stimulation of NF-B activity by mutants of LMP-1 indicate that this stimulation is not dependent on the ability of LMP-1 to patch. DNAs expressing LMP-1 or a derivative were cotransfected into 293 cells along with a DNA encoding a luciferase reporter gene under the control of NF-
B-responsive elements (Mitchell & Sugden, 1995
). These cells were grown for 48 h, harvested, lysed and the luciferase was activity measured. The level of stimulation of NF-
B activity by each derivative was normalized for the level of protein expressed via quantitative Western blotting (Sandberg et al., 1997
). The results of these assays are shown in Table 1(b)
, and show that stimulation of NF-
B activity, as measured by luciferase activity, is not dependent on patching of LMP. By way of examples, 6M EE, which does not patch, has a wild-type topology within the plasma membrane and stimulates NF-
B to near wild-type levels. 4M HA, which also does not patch but assumes a wild-type topology, upregulates NF-
B to greater than wild-type levels. N
43 neither stimulates NF-
B activity nor patches. These findings show that stimulation of NF-
B activity by LMP-1 and its patching are genetically separable.
We propose that patching of LMP-1 reflects a higher-order assemblage that is not required for its stimulation of NF-B activity, but is compatible with this stimulation (Table 1b)
. Patching may be mediated by association of LMP-1 with cellular molecules, for example, an association with glycosphingolipid-rich membrane domains (Clausse et al., 1997
), but this association does not impede LMP-1s stimulation of NF-
B activity. The contribution patching by LMP-1 makes during the life-cycle of EBV is likely to be important because the two regions of LMP-1 that we have identified to be required for patching are highly conserved in different strains of EBV (Miller et al., 1994
; Sandvej et al., 1997
). The conservation of the sequences of the first two transmembrane-spanning regions in particular is consistent with these regions contributing a specific activity to patching beyond that of being hydrophobic.
![]() |
Footnotes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() |
---|
Baichwal, V. R. & Sugden, B. (1987). Posttranslational processing of an EpsteinBarr virus-encoded membrane protein expressed in cells transformed by EpsteinBarr virus. Journal of Virology 61, 866-875.[Medline]
Cicchetti, P., Mayer, B. J., Thiel, G. & Baltimore, D. (1992). Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257, 803-806.[Medline]
Clausse, B., Fizazi, K., Walczak, V., Tetaud, C., Wiels, J., Tursz, T. & Busson, P. (1997). High concentrations of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology 228, 285-293.[Medline]
Feng, S., Chen, J. K., Yu, H., Simon, J. A. & Schreiber, S. L. (1994). Two binding orientations for peptides to the src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247.[Medline]
Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D. & Hammerschmidt, W. (1997). Latent membrane protein 1 of EpsteinBarr virus mimics a constitutively active receptor molecule. EMBO Journal 16, 6131-6140.
Grussenmeyer, T., Scheidtmann, K. H., Hutchinson, M. A., Eckhart, W. & Walter, G. (1985). Complexes of polyoma virus medium T antigen and cellular proteins. Proceedings of the National Academy of Sciences, USA 82, 7952-7954.[Abstract]
Hammarskjold, M. & Simurda, M. C. (1992). EpsteinBarr virus latent membrane protein transactivates the HIV type 1 long terminal repeat through induction of NF-B activity. Journal of Virology 66, 6496-6501.[Abstract]
Izumi, K. M., Kaye, K. M. & Kieff, E. D. (1994). EpsteinBarr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. Journal of Virology 68, 4369-4376.[Abstract]
Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). EpsteinBarr virus latent membrane protein-1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, USA 90, 9150-9154.[Abstract]
Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. & Hammerschmidt, W. (1997). EpsteinBarr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO Journal 16, 6478-6485.
Kilger, E., Kieser, A., Baumann, M. & Hammerschmidt, W. (1998). EpsteinBarr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO Journal 17, 1700-1709.
Koch, C. A., Anderson, D., Moran, M. F., Ellis, C. & Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.[Medline]
Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F. & Dixit, V. M. (1992). The EpsteinBarr virus LMP-1 gene product induces A20 zinc finger protein expression by activating NF-B. Journal of Biological Chemistry 267, 24157-24160.
Liebowitz, D., Wang, D. & Kieff, E. (1986). Orientation and patching of the latent infection membrane protein encoded by EpsteinBarr virus. Journal of Virology 58, 233-237.[Medline]
Liebowitz, D., Kopan, R., Fuchs, E., Sample, J. & Kieff, E. (1987). An EpsteinBarr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7, 2299-2308.[Medline]
Mann, K. P. & Thorley-Lawson, D. (1987). Posttranslational processing of the EpsteinBarr virus-encoded p63/LMP protein. Journal of Virology 61, 2100-2108.[Medline]
Mann, K. P., Staunton, P. & Thorely-Lawson, D. (1985). EpsteinBarr virus-encoded protein found in the plasma membrane of transformed cells. Journal of Virology 55, 710-720.[Medline]
Martin, J. & Sugden, B. (1991a). The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth and Differentiation 2, 653-660.[Abstract]
Martin, J. & Sugden, B. (1991b). Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization and cytoskeletal association. Journal of Virology 65, 3246-3258.[Medline]
Mayer, B. J. & Baltimore, D. (1993). Signaling through SH2 and SH3 domains. Trends in Cell Biology 3, 8-13.
Miller, W. E., Edwards, R. H., Walling, D. M. & Raab-Traub, N. (1994). Sequence variation in the EpsteinBarr virus latent membrane protein 1. Journal of General Virology 75, 2729-2740.[Abstract]
Mitchell, T. & Sugden, B. (1995). Stimulation of NF-B-mediated transcription by mutant derivatives of the latent membrane protein of EpsteinBarr virus. Journal of Virology 69, 2968-2976.[Abstract]
Paulie, S., Rosen, A., Ehlin-Henriksson, B., Braesch-Andersen, S., Jakobson, E., Koho, H. & Perlmann, P. (1989). The human B lymphocyte and carcinoma antigen Cdw40, is a phosphoprotein involved in growth signal transduction. Journal of Immunology 142, 590-595.
Ren, R., Mayer, B., Cicchetti, P. & Baltimore, D. (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161.[Medline]
Rothe, M., Sarma, V., Dixit, V. M. & Goeddel, D. V. (1995). TRAF2-mediated activation of NF-B by TNR receptor 2 and CD40. Science 269, 1424-1427.[Medline]
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Introduction of recombinant vectors into mammalian cells. In Molecular Cloning: A Laboratory Manual, 2nd edn, pp. 16.3016.40. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Sandberg, M., Hammerschmidt, W. & Sugden, B. (1997). Characterization of LMP-1s association with TRAF1, TRAF2, and TRAF3. Journal of Virology 71, 4649-4656.[Abstract]
Sandvej, K., Gratama, J. W., Munch, M., Zhou, X., Bolhuis, R. L. H., Andresen, B. S., Gregersen, N. & Hamilton-Dutoit, S. (1997). Sequence analysis of the EpsteinBarr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90, 323-330.
Speck, S. H. & Strominger, J. L. (1989). Transcription of EpsteinBarr virus in latently infected, growth transformed lymphocytes. In Tumorigenic DNA Viruses: Advances in Viral Oncology, pp. 133-150. Edited by G. Klein. New York: Raven Press.
Wilson, P. T. & Bourne, H. R. (1995). Fatty acylation of alpha z: effects of palmitoylation and myristoylation on alpha z signaling. Journal of Biological Chemistry 270, 9667-9675.
Wilson, I. A., Niman, H. L., Houghten, R. A., Cherenson, A. R., Connolly, M. L. & Lerner, R. A. (1984). The structure of an antigenic determinant in a protein. Cell 37, 767-778.[Medline]
Received 10 May 1999;
accepted 3 August 1999.